Trachelogenin - CAS 34209-69-3

Trachelogenin ((-) -Trachelogenin), isolated from Combretum fruticosum, is an HCV entry inhibitor with anti-proliferative effects. Its mechanism is related to affecting the phosphorylation of key proteins such as β-Catenin, c-Myc and GSK3 in the β-Catenin signaling pathway. chemical and concentration-dependent. Trachelogenin has antiviral, anti-inflammatory and analgesic activities with IC50 of 0.325 and 0.259 μg/mL in HCVcc and HCVpp models, respectively.

Virus Protease, Wnt/beta-catenin, c-Myc, HCV Protease

Stem Cells, Cytoskeletal Signaling, Cell Cycle/Checkpoint, Microbiology/Virology, Proteases/Proteasome

34209-69-3

0.9987

C21H24O7

388.41

COc1cc(C[C@]2(O)[C@@H](Cc3ccc(OC)c(OC)c3)COC2=O)ccc1O

-20°C

Ice Packs

Natural Product